Skip to main content

ADVERTISEMENT

Zelma Chiesa Fuxench, MD, MSCE

NEA Approved Features
10/31/2018
This article explores the literature on the overall risk of malignancy in AD and the risk associated with use of common topical and immunosuppressive medications, as well as newer therapeutic options.
This article explores the literature on the overall risk of malignancy in AD and the risk associated with use of common topical and immunosuppressive medications, as well as newer therapeutic options.
This article explores the...
10/31/2018
The Dermatologist